Download PDF
Thromb Haemost 1999; 82(05): 1560-1561
DOI: 10.1055/s-0037-1614876
Letters to the Editor
Schattauer GmbH

The Importance of Differentiating ReoPro (c7E3 Abciximab) Induced Thrombocytopenia from Heparin-induced Thrombocytopenia

S. J. Davidson
1   From the Departments of Haematology, Royal Brompton Hospital, London, UK
,
N. Turner
2   Departments of Cardiology, Royal Brompton Hospital, London, UK
,
J. R. Clague
2   Departments of Cardiology, Royal Brompton Hospital, London, UK
,
P. J. Oldershaw
2   Departments of Cardiology, Royal Brompton Hospital, London, UK
,
J. F. Burman
1   From the Departments of Haematology, Royal Brompton Hospital, London, UK
› Author Affiliations
Further Information

Publication History

Received 04 March 1999

Accepted 16 June 1999

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994; 343: 881-6.
    CrossrefPubMedGoogle Scholar
  • 2 Christopoulos CG, Machin SJ. A new type of pseudothrombocytopenia: EDTA-mediated agglutination of platelets bearing Fab fragments of a chimaeric antibody. Br J Haematol 1994; 87: 650-2.
    CrossrefPubMedGoogle Scholar
  • 3 Griffiths E, Dzik WH. Assays for heparin-induced thrombocytopenia. Transfus Med 1997; 7: 1-11.
    CrossrefPubMedGoogle Scholar
  • 4 Berkowitz SD, Harrington RA, Rund MM, Tcheng JE. Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy. Circulation 1997; 95: 809-13.
    CrossrefPubMedGoogle Scholar
  • 5 Kereiakes DJ, Essell JH, Abbottsmith CW, Broderick TM, Runyon JP. Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion. Am J Cardiol 1996; 78: 1161-3.
    CrossrefPubMedGoogle Scholar
  • 6 Coller BS. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Haemost 1997; 78: 730-5.
    Article in Thieme ConnectPubMedGoogle Scholar